01 ALPRAZOLAM (4)
01 UCB INC (4)
01 TABLET, ORALLY DISINTEGRATING;ORAL (4)
01 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
03 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
04 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (4)
19
UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ALPRAZOLAM, with a corresponding application number 21726 and regulatory information .
proudly manufactured in the
approval since 2005-01-19
UCB Pharma S.A's NIRAVAM TABLET, ORALLY DISINTEGRATING;ORAL, medication with 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALPRAZOLAM.
18
UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ALPRAZOLAM, with a corresponding application number 21726 and regulatory information .
proudly manufactured in the
approval since 2005-01-19
UCB Pharma S.A's NIRAVAM TABLET, ORALLY DISINTEGRATING;ORAL, medication with 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALPRAZOLAM.
17
UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ALPRAZOLAM, with a corresponding application number 21726 and regulatory information .
proudly manufactured in the
approval since 2005-01-19
UCB Pharma S.A's NIRAVAM TABLET, ORALLY DISINTEGRATING;ORAL, medication with 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALPRAZOLAM.
16
UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ALPRAZOLAM, with a corresponding application number 21726 and regulatory information .
proudly manufactured in the
approval since 2005-01-19
UCB Pharma S.A's NIRAVAM TABLET, ORALLY DISINTEGRATING;ORAL, medication with 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALPRAZOLAM.